Literature DB >> 11063498

Combined cell culture enzyme-linked immunosorbent assay for quantification of poliovirus neutralization- relevant antibodies.

A F Wahby1.   

Abstract

A combined cell culture enzyme-linked immunosorbent assay (CCC-ELISA) was developed for measuring the neutralizing antipoliovirus antibodies in human sera. The binding of different concentrations of each of the three poliovirus types to BGM cells in the presence and absence of a constant dilution from each test and reference serum was measured in the CCC-ELISA. The titers of the viruses neutralized by each serum were measured with the titration curves and used for interpretation of neutralizing titers to the three poliovirus types. Analysis of human sera revealed that the sensitivity and specificity of the CCC-ELISA and the microneutralization assay were comparable. The CCC-ELISA is nonsubjective, rapid, and highly reproducible. Furthermore, the CCC-ELISA could potentially be used as a seroepidemiologic tool for assessment of the humoral response to the cell culture infectious viruses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063498      PMCID: PMC95985          DOI: 10.1128/CDLI.7.6.915-919.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  18 in total

1.  Antigenic structure of polioviruses of serotypes 1, 2 and 3.

Authors:  P D Minor; M Ferguson; D M Evans; J W Almond; J P Icenogle
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

2.  Interaction of poliovirus with its purified receptor and conformational alteration in the virion.

Authors:  M Arita; S Koike; J Aoki; H Horie; A Nomoto
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test.

Authors:  M M Herremans; J H Reimerink; A Ras; H G Van Der Avoort; T G Kimman; A M Van Loon; M A Conyn-Van Spaendonck; M P Koopmans
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

4.  Three-dimensional structure of poliovirus at 2.9 A resolution.

Authors:  J M Hogle; M Chow; D J Filman
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

5.  Hit-and-run neutralization of poliovirus.

Authors:  P Brioen; B Rombaut; A Boeyé
Journal:  J Gen Virol       Date:  1985-11       Impact factor: 3.891

6.  Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands.

Authors:  M M Herremans; A M van Loon; J H Reimerink; H C Rümke; H G van der Avoort; T G Kimman; M P Koopmans
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

7.  The interaction of neutralized poliovirus with HeLa cells. I. Adsorption.

Authors:  B Mandel
Journal:  Virology       Date:  1967-02       Impact factor: 3.616

8.  Enzyme-linked immunosorbent assay-based inhibition test for neutralizing antibodies to polioviruses as an alternative to the neutralization test in tissue culture.

Authors:  G Edevåg; B Wahren; A D Osterhaus; V A Sundqvist; M Granström
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

9.  Evaluation of an enzyme-linked immunosorbent assay based on binding inhibition for type-specific quantification of poliovirus neutralization-relevant antibodies.

Authors:  M Hashido; H Horie; S Abe; Y Doi; S Hashizume; M Agboatwalla; S Isomura; O Nishio; A Hagiwara; S Inouye
Journal:  Microbiol Immunol       Date:  1999       Impact factor: 1.955

10.  Antibodies against viral nonstructural proteins in response to infection with poliovirus.

Authors:  E Ehrenfeld; D Brown; X Y Jia; D F Summers
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

View more
  1 in total

1.  Cryo-EM structure of eastern equine encephalitis virus in complex with heparan sulfate analogues.

Authors:  Chun-Liang Chen; S Saif Hasan; Thomas Klose; Yingyuan Sun; Geeta Buda; Chengqun Sun; William B Klimstra; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-03       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.